Donate
Hemangiosarcoma is a devastatingly
common cancer.
Step by step, we are progressing toward a better tomorrow for this prognosis, but right now, the best source of support we have is each other.
By donating to our mission, you can help push forward the clinical trial that may unveil the next breakthrough or come to the aid of families who cannot afford the treatment that could give them some precious extra time to enjoy with their pups.
Give in Honor & Give in Memory
The love we share with our dogs is expansive.
Giving in honor to mark a special milestone or in memory of your wonderful pet is a beautiful way to celebrate them. Your tribute to your dog can make a significant difference in the life of another.
You can share more about your story in the donation form, and if you want to, we’d love a picture of your dear canine companion to feature on our memory wall.
Additional Ways to Give
We gladly accept donations through corporate sponsorships from committed organizations and matching employee gifts to amplify the impact of your support. If you’d like to donate in another way, please contact us.
Recent Updates

UF Study Uncovers New Insights into Hemangiosarcoma
They hope these findings will help refine treatment strategies and improve outcomes.
Published on: January 22, 2025

Study Finds Most Splenectomies Have Benign Diagnoses
Splenectomies may seem like an unpredictable risk, but the results of this retrospective study could change that belief.
Published on: January 21, 2025

Cytodiagnosis of Hemangiosarcoma in Dogs
Hemangiosarcoma can have a very heterogeneous cytologic appearance that can be used to support a suspected diagnosis
Published on: January 21, 2025

Early Detection of Canine Hemangiosarcoma via cfDNA
Techniques show promise for early, non-invasive detection of canine hemangiosarcoma through cfDNA fragmentation and CNAs using machine learning.
Published on: January 24, 2025

EGFR’s Role in PI3K/AKT Dysregulation in Canine Sarcoma
Weak PTEN and strong EGFR expressions were linked to high-grade tumors, with EGFR activation of the PI3K/AKT pathway suggesting potential targets for canine soft tissue sarcoma therapy.
Published on: January 20, 2025

Incidence of Splenic Malignancy in Dogs Undergoing Splenectomy
The results confirmed a low frequency of malignant splenic lesions and HSA in dogs, with a majority of diagnoses being benign masses.
Published on: January 20, 2025